Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Stereotactic Ablative Radiotherapy (SABR)
Locations
1
United States
Stanford Cancer Center
Palo Alto, California, United States
Start Date
February 11, 2013
Primary Completion Date
August 2, 2021
Completion Date
August 2, 2021
Last Updated
July 11, 2024
NCT06891755
NCT05825261
NCT03263130
NCT02796937
NCT04930289
NCT01969344
Lead Sponsor
Stanford University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions